Viewers Cautioned on Televised Medical Talk Show Recommendations
|
By HospiMedica International staff writers Posted on 05 Jan 2015 |

Image: Study authors Mike Kolber, Christina Korownyck, and Mike Allan (Photo courtesy of the University of Alberta).
A new study warns that the public should be skeptical of recommendations made on mainstream television medical talk shows, as they often lack adequate evidence or are contradicted by the best available evidence.
Researchers at the University of Alberta (Edmonton, Canada) chose two internationally syndicated medical talk shows to analyze: The Dr. Oz Show and The Doctors. Each show was recorded every day from January 2013 to April 2013. The researchers then randomly selected 40 episodes of each show and had two team members watch every episode independently, recording topics, recommendations made, and who was making the recommendations. Two other researchers also watched the episodes and review the recommendations, focusing on benefits mentioned, if the magnitude of the benefit was quantified, costs, and conflict of interest.
The researchers found evidence to support 54% of the 160 randomly selected recommendations (80 from each show). For The Dr. Oz Show, evidence supported 46%, contradicted 15%, and was not found for 39%. For The Doctors, evidence supported 63%, contradicted 14%, and was not found for 24%. Believable or somewhat believable evidence supported 33% of the recommendations on The Dr. Oz Show and 53% on The Doctors. The most common recommendation category on The Dr. Oz Show was dietary advice (39%) and on The Doctors was to consult a healthcare provider (18%).
Further findings included a specific benefit for 43% and 41% of the recommendations made on the shows respectively. The magnitude of benefit was described for 17% of the recommendations on The Dr. Oz Show and 11% on The Doctors. Disclosure of potential conflicts of interest accompanied only 0.4% of recommendations for both shows. The study was published in the Christmas edition of the British Medical Journal (BMJ), which was dedicated to media studies.
“Some patients come in and say 'I heard on Dr. Oz yesterday that we should all be doing this.' And then we're left scrambling in our office to try to find answers. It got us reflecting, what's being said there? What kinds of things are being recommended and what kind of information is being provided?” said lead author Christina Korownyk, MD, an associate professor in the department of family medicine. “Frequently you're not getting enough information and without doing the research you won't know if it's supported by evidence or not; the research supporting any of these recommendations is frequently absent, contradictory, or of poor quality.”
Related Links:
University of Alberta
Researchers at the University of Alberta (Edmonton, Canada) chose two internationally syndicated medical talk shows to analyze: The Dr. Oz Show and The Doctors. Each show was recorded every day from January 2013 to April 2013. The researchers then randomly selected 40 episodes of each show and had two team members watch every episode independently, recording topics, recommendations made, and who was making the recommendations. Two other researchers also watched the episodes and review the recommendations, focusing on benefits mentioned, if the magnitude of the benefit was quantified, costs, and conflict of interest.
The researchers found evidence to support 54% of the 160 randomly selected recommendations (80 from each show). For The Dr. Oz Show, evidence supported 46%, contradicted 15%, and was not found for 39%. For The Doctors, evidence supported 63%, contradicted 14%, and was not found for 24%. Believable or somewhat believable evidence supported 33% of the recommendations on The Dr. Oz Show and 53% on The Doctors. The most common recommendation category on The Dr. Oz Show was dietary advice (39%) and on The Doctors was to consult a healthcare provider (18%).
Further findings included a specific benefit for 43% and 41% of the recommendations made on the shows respectively. The magnitude of benefit was described for 17% of the recommendations on The Dr. Oz Show and 11% on The Doctors. Disclosure of potential conflicts of interest accompanied only 0.4% of recommendations for both shows. The study was published in the Christmas edition of the British Medical Journal (BMJ), which was dedicated to media studies.
“Some patients come in and say 'I heard on Dr. Oz yesterday that we should all be doing this.' And then we're left scrambling in our office to try to find answers. It got us reflecting, what's being said there? What kinds of things are being recommended and what kind of information is being provided?” said lead author Christina Korownyk, MD, an associate professor in the department of family medicine. “Frequently you're not getting enough information and without doing the research you won't know if it's supported by evidence or not; the research supporting any of these recommendations is frequently absent, contradictory, or of poor quality.”
Related Links:
University of Alberta
Latest Health IT News
- AI-Native EHR Achieves EU Medical Device Certification
- EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
- AI System Detects and Quantifies Chronic Subdural Hematoma
- Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
- Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
- Voice-Driven AI System Enables Structured GI Procedure Documentation
- EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Channels
Artificial Intelligence
view channel
AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure
Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
AI Tool Predicts Unplanned Care and Symptom Burden in Cancer Survivors
Unplanned emergency visits and hospitalizations remain common in cancer survivorship, when routine clinical contact often tapers while new symptoms emerge. These events reflect unmet needs and disrupt... Read moreCritical Care
view channel
Home Blood Pressure Telemonitoring Linked to Fewer Cardiovascular Events
Hypertension is a leading cause of myocardial infarction and stroke, yet it often progresses without symptoms. Uncontrolled blood pressure contributes to avoidable hospitalizations, deaths, and health system burden.... Read more
Tiny Wearable Patch Tracks Heart and Respiratory Changes at Home
Auscultation and cardiorespiratory monitoring are typically limited to brief, clinic-based assessments. These intermittent checks can miss evolving abnormalities and place added burden on patients who... Read moreSurgical Techniques
view channel
Expandable Lumbar Fusion System Gains FDA 510(k) Clearance
Xenix Medical (Orlando, FL, USA) has received U.S. Food and Drug Administration 510(k) clearance and initiated full commercial launch of the Lux Expandable Lumbar Interbody Fusion System.... Read more
New CAR T-Cell Therapy Enables Transplants in Hard-to-Match Kidney Patients
Highly sensitized kidney transplant candidates have extremely high levels of anti-donor antibodies that block matching and prolong dialysis. These patients face long wait times and increased morbidity... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read morePoint of Care
view channel
Handheld AI Device for Point-of-Care Skin Lesion Assessment Receives CE Mark
DermaSensor (Miami, FL, USA) has received a Class IIb CE Mark for its handheld DermaSensor device, marking the start of the company’s global expansion strategy. The certification demonstrates conformity... Read more
Portable Immunoassay System Advances Toward Point-of-Care Biomarker Testing
Proxim Diagnostics Corp. (Santa Clara, CA, USA) has announced that its Profile System, a handheld point-of-care immunoassay platform, has completed development. The milestone includes completion... Read more
Portable MRI System Accelerates Emergency Brain Imaging and Triage
Emergency departments frequently face delays accessing conventional magnetic resonance imaging (MRI) for patients with suspected neurological emergencies. Such waits can slow triage, prolong boarding,... Read more







